On the contrary, the sensitivity to discriminate CC from CIN 2 to CIN 3 had an increasing trend for serological markers anti-VLPs-L1 (0%–60%) and anti-E4 (0%–100%) with increasing years of TSA.
← all excerpts
Validation of Serological Antibody Profiles Against Human Papillomavirus Type 16 Antigens as Markers for Early Detection of Cervical Cancer.
1
—
—